Compare GSK plc (GSK) vs Kaltura Inc (KLTR) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
GSK plc vs Kaltura Inc — how do they compare? GSK plc trades at $50.37 (market cap $102.60B), while Kaltura Inc trades at $1.63 (market cap $249.42M). The key difference: GSK plc is far larger — about 411.4× Kaltura Inc's market cap, and GSK plc pays a 3.57% dividend while Kaltura Inc pays none. Which is the better fit depends on your goals.
| GSK | KLTR | |
|---|---|---|
Market Cap | $102.60B | $249.42M |
Sector | Health | Technology |
52-Week High | $61.18 | $1.89 |
52-Week Low | $38.22 | $1.08 |
Enterprise Value | $123.04B | $261.64M |
Dividend Yield | 3.57% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
GSK trades at $50.27, down 3.62% today, with a bearish technical signal but strong fundamentals including a P/E of 16.02 and net income margin of 14.52%. Recent quarters show earnings beats, and the company announced a $2.52 billion cost-saving plan to boost its drug pipeline. Cash flow from operations remains robust at $7.74 billion for 2025.
The outlook is mixed: analyst consensus leans hold (55.18%) amid valuation concerns, but revenue growth and pipeline investments support long-term potential. Key risks include competitive pressures and regulatory uncertainty, as highlighted by recent news on vaccine policies. The stock offers a dividend yield with payments scheduled through 2026.
Kaltura (KLTR) trades at $1.58, down 3.66% today, with a bullish technical outlook supported by moving averages. The company shows improving fundamentals with revenue stabilizing around $181M and net losses narrowing from -$68M in 2022 to -$12M in 2025. Recent Q2 2026 earnings beat expectations, and the company has received multiple industry recognitions for its AI and video platform leadership.
While Kaltura demonstrates operational improvement and strong analyst support (44% buy ratings), significant risks remain including persistent negative ROE (-134%), high valuation multiples (EV/EBITDA 336x), and insider selling. The stock offers speculative upside if AI initiatives drive profitability, but requires careful risk management given current financial metrics.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About GSK plc
In the pharmaceutical industry, GSK ranks as one of the largest firms by total sales. The company wields its might across several therapeutic classes, including respiratory, cancer, and antiviral, as well as vaccines. GSK uses joint ventures to gain additional scale in certain markets like HIV.
Read more on GSK →About Kaltura Inc
Kaltura Inc provides live and on-demand video SaaS solutions to thousands of organizations around the world, engaging hundreds of millions of viewers at home, at work, and school. It also offers specialized industry solutions, including Learning Management System Video, Lecture Capture, and Virtual Classroom for educational institutions, as well as a TV Solution for media and telecom companies. It operates in two reporting segments: (i) Enterprise, Education, and Technology (EE&T)
Read more on KLTR →
